Unlocking the secret drivers of deadly pancreatic cancer: New target offers hope for treatment

Researchers identify a super-enhancer-regulated RNA-binding protein cascade that drives the growth of pancreatic ductal adenocarcinoma, a deadly form of pancreatic cancer. The discovery offers a promising new avenue for targeted therapy, potentially sidestepping severe side effects associated with other treatments.

MeCo Score May Predict Metastatic Progression in Breast Cancer

Clinical data from patients in two retrospective cohorts spanning both early- and late-stage breast cancer demonstrate that the mechanical conditioning (MeCo) score is the first

January 6, 2024

Lilly to acquire cancer biotech Scorpion, which shares a co-founder with Loxo

Eli Lilly, the most talked-about pharmaceutical company in recent years, is buying cancer startup Scorpion Therapeutics about half a year after its Sign up to

January 14, 2025

Review finds no proven clinical benefit to strict salt restriction for patients with heart failure

For decades, it’s been thought that people with heart failure should drastically reduce their dietary salt intake, but some studies have suggested that salt restriction

June 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.